Name
Session V: Chronic Myeloid Leukemia
Date & Time
Thursday, September 10, 2026, 10:25 AM - 11:47 AM
Description

Session V: Chronic Myeloid Leukemia 

Session Chairs: Michael Deininger, MD, PhD and Jorge E. Cortés, MD

STAMP: Advantages and Pitfalls | Andreas Hochhaus, MD | Jena University Hospital, Jena, Germany

Good Response but Not DMR: What to Do | Ehab L. Atallah, MD | Medical College of Wisconsin, Milwaukee, Wisconsin, USA

AGA in CML: Potential Role and Therapeutic Strategies | Vivian Oehler, MD | Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Is There Still a Role for Allogeneic Transplant in CML? | Hugues de Lavallade, MD, PhD | Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom

Oral Abstract | TBD | Speaker | Affiliation

Ehab Atallah Jorge Cortés Hugues De Lavallade Michael Deininger Andreas Hochhaus Vivian Oehler
Location Name
General Assembly, Level 3 GRB Convention Center